Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calidrux Lifesciences is a research-driven biotechnology company based in Hyderabad, India, focused on the discovery and development of novel small molecule therapeutics. The company utilizes structure-based drug design and advanced medicinal chemistry to target high-unmet-need areas, particularly in oncology, immunology, and metabolic disorders. Calidrux aims to develop highly selective and potent inhibitors that offer improved safety and efficacy profiles compared to existing treatments. Currently operating in the pre-clinical stage, the firm is advancing a proprietary pipeline of candidates toward IND-enabling studies. The leadership team brings extensive experience from global pharmaceutical organizations to drive their drug discovery programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calidrux Lifesciences.